Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In contrast, determination...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Rapid and Portable EmDEA-Based Diagnostic System for On-Site Detection of <i>Erwinia amylovora</i>, the Causal Agent of Fire Blight.

Plant disease·2026
Same author

Paeonol alleviates intrauterine adhesion by suppressing endometrial stromal cell activation via AKT1, based on network pharmacology.

Reproduction, fertility, and development·2026
Same author

Design of Gel Polymer Electrolytes With High Ionic Conductivity via Anion-Cation Synergy for Stable-Interface Lithium Metal Batteries.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

In vivo mapping of peroxisome dynamics and pexophagy using PO-TRG and CA-PO-TRG reporter mice.

The Journal of cell biology·2025
Same author

Biomimetic 3D-printed bilayered scaffold with stem cell delivery for rabbit vaginal regeneration.

Biomaterials advances·2025
Same author

Host plant and soil nutrient filters mediate long-term grazing on arbuscular mycorrhizal fungi in desert grasslands.

The New phytologist·2025

Related Experiment Video

Updated: Jun 16, 2026

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

ETV2 for endothelial fate specification.

Zeyu Song1, Jiahua Zheng2, Jing Liu3

  • 1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Advanced Center of Cellular Homeostasis and Aging-Related Diseases, Clinical Stem Cell Research Center, Peking University Third Hospital, Peking University, Beijing 100191, China.

Current Opinion in Genetics & Development
|June 13, 2026
PubMed
Summary

The transcription factor ETV2 drives endothelial cell differentiation for vascular regeneration and organoid development. This review explores ETV2

More Related Videos

Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells
04:23

Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells

Published on: March 31, 2021

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

Related Experiment Videos

Last Updated: Jun 16, 2026

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells
04:23

Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells

Published on: March 31, 2021

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Regenerative Medicine

Background:

  • Vascular regeneration is crucial for treating ischemic diseases and creating organoid models.
  • The transcription factor ETS variant 2 (ETV2) is a key regulator of embryonic angiogenesis in model organisms.
  • ETV2 controls endothelial cell (EC) differentiation during vascular development.

Purpose of the Study:

  • To systematically review ETV2's molecular mechanisms in endothelial fate specification.
  • To highlight strategies for manipulating vascular cell differentiation in vitro using ETV2.
  • To discuss challenges in translating ETV2-based cell engineering for clinical applications.

Main Methods:

  • Systematic literature review of ETV2's role in vascular development and cell differentiation.
  • Analysis of in vitro studies demonstrating ETV2's capacity to induce endothelial lineage.
  • Discussion of current ETV2-based cell engineering technologies.

Main Results:

  • ETV2 is essential for embryonic angiogenesis and orchestrates vascular development.
  • ETV2 can efficiently induce differentiation or transdifferentiation of stem and somatic cells into ECs.
  • ETV2's function extends beyond embryonic development to in vitro cell manipulation.

Conclusions:

  • ETV2 holds significant potential for vascular regenerative therapies.
  • ETV2 facilitates the in vitro generation of endothelial cells for research and therapeutic use.
  • Overcoming translational challenges is key for the clinical application of ETV2-based technologies.